BSIM Therapeutics

Manufacturing · Portugal · 1-10 Employees

View Company Info for Free

Overview

Headquarters

Rua Pedro Nunes, Coimbra, Portugal

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About BSIM Therapeutics

BSIM Therapeutics focuses on developing innovative medicines for patients affected by transthyretin amyloidoses, specifically targeting various clinical manifestations such as polyneuropathy, cardiomyopathy, and oculopathy. The company aims to improve patient lives through next-generation transthyretin stabilizers. Their recent achievements include the selection of candidate compounds for Transthyretin Amyloid Cardiomyopathy and the awarding of multiple patents. BSIM Therapeutics actively participates in events related to ATTR amyloidosis to engage with both patients and healthcare professionals.Explore more
BSIM Therapeutics's Social MediaPopular SearchesBSIM TherapeuticsBsim Therapeutics SASIC Code 28,283NAICS Code 32,325Show more

Is BSIM Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

BSIM Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

BSIM Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BSIM Therapeutics.

BSIM Therapeutics Tech Stack

A closer look at the technologies used by BSIM Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding BSIM Therapeutics

What is BSIM Therapeutics's official website?
BSIM Therapeutics's official website is www.bsimtx.com
What is BSIM Therapeutics's Revenue?
BSIM Therapeutics's revenue is <$5 Million
What is BSIM Therapeutics's SIC code?
BSIM Therapeutics's SIC: 28,283
What is BSIM Therapeutics's NAICS code?
BSIM Therapeutics's NAICS: 32,325
How many employees does BSIM Therapeutics have?
BSIM Therapeutics has 1-10 employees
What industry does BSIM Therapeutics belong to?
BSIM Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What technology does BSIM Therapeutics use?
Some of the popular technologies that BSIM Therapeutics uses are: Google Universal Analytics, Google Font API, Google Analytics, jQuery
What does BSIM Therapeutics do?

BSIM Therapeutics focuses on developing innovative medicines for patients affected by transthyretin amyloidoses, specifically targeting various clinical manifestations such as polyneuropathy, cardiomyopathy, and oculopathy. The company aims to improve patient lives through next-generation transthyretin stabilizers. Their recent achievements include... the selection of candidate compounds for Transthyretin Amyloid Cardiomyopathy and the awarding of multiple patents. BSIM Therapeutics actively participates in events related to ATTR amyloidosis to engage with both patients and healthcare professionals.Read More

What are BSIM Therapeutics social media links?
BSIM Therapeutics Linkedin page BSIM Therapeutics Twitter page BSIM Therapeutics Facebook page
Is BSIM Therapeutics a public company?
BSIM Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about BSIM Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.